chr2-219222311-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001077198.3(ATG9A):c.1988C>T(p.Ala663Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000223 in 1,613,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001077198.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG9A | NM_001077198.3 | c.1988C>T | p.Ala663Val | missense_variant | 12/16 | ENST00000361242.9 | NP_001070666.1 | |
ATG9A | NM_024085.5 | c.1988C>T | p.Ala663Val | missense_variant | 11/15 | NP_076990.4 | ||
ATG9A | NR_104255.2 | n.2112C>T | non_coding_transcript_exon_variant | 12/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG9A | ENST00000361242.9 | c.1988C>T | p.Ala663Val | missense_variant | 12/16 | 2 | NM_001077198.3 | ENSP00000355173.4 | ||
ENSG00000284820 | ENST00000446716.5 | n.233C>T | non_coding_transcript_exon_variant | 2/22 | 2 | ENSP00000398528.1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000158 AC: 39AN: 247006Hom.: 0 AF XY: 0.000193 AC XY: 26AN XY: 134632
GnomAD4 exome AF: 0.000228 AC: 333AN: 1461038Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 176AN XY: 726832
GnomAD4 genome AF: 0.000171 AC: 26AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74346
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at